Short answer: Datascan, the family-owned pharmacy software company based in Bohemia, New York, has publicly committed to staying independently owned. President and owner Kevin Minassian says the company walked away from a serious acquisition offer and will not be positioned for a private-equity sale or corporate roll-up. For pharmacy owners, the announcement matters less as a corporate milestone and more as a prompt: vendor ownership is now a real operating risk, and most owners have never priced it.
The Short Answer
Datascan announced on August 6 that it intends to remain independently owned and dedicated exclusively to independent community pharmacies. The company framed the decision against a decade of consolidation in pharmacy software, during which competing platforms have been acquired, merged, discontinued or folded into larger corporate structures.
A commitment is not a contract. But it is a public position a vendor can be held to, and it is more than most software companies in this category have been willing to say out loud.
What Datascan Actually Announced
The company said it is not being prepared for an outside sale or a private-equity exit. Future succession, according to the announcement, could involve continued family ownership or an internal transition involving members of the Datascan team.
Minassian also disclosed that Datascan has received repeated acquisition interest over the last several years, and that one approach progressed far enough that he seriously considered selling. The financial offer was significant. The proposed terms changed late in the process, and Datascan walked away.
“We are not building Datascan so we can package it up and sell it to the highest bidder. We are building it to last.” — Kevin Minassian, President and Owner, Datascan
Minassian said the experience clarified his thinking. “When the deal changed at the last minute, we walked away. At the time, it was frustrating. Looking back, I am grateful it happened because it forced me to stop thinking about what Datascan might be worth to a buyer and start thinking about what Datascan is worth to the people who depend on it.”
Why Vendor Ownership Became an Operating Risk
For most of the last twenty years, pharmacy owners chose software on features, price and support. Ownership structure was not on the checklist. That has changed, because the consequences of an ownership change now land directly on the pharmacy.
Owners who have been through an acquisition tend to describe the same sequence: the product roadmap slows, the support team turns over, renewal pricing moves, and new requirements appear that were not part of the original relationship. In the worst cases the platform is sunset entirely and the pharmacy is given a migration window it did not ask for.
None of that is unique to pharmacy. It is the standard playbook for software businesses acquired on a multiple, where the buyer’s return depends on raising revenue per customer and lowering cost to serve. Pharmacy is simply a category where the switching cost is unusually brutal — a system conversion touches dispensing, claims, inventory, signature capture, delivery and every workflow the staff has built around them.
The Processor and Switch Question
The most concrete part of Datascan’s announcement is not the ownership pledge. It is the commitment on vendor choice.
The company said it will not require customers to use a particular credit card processor, insurance claims switch or other third-party vendor solely because the arrangement creates an additional revenue stream for Datascan.
“We do not believe a pharmacy software company should make money by controlling every transaction that passes through the pharmacy,” Minassian said. “Our job is to provide the technology that helps the pharmacy operate more efficiently, remain profitable and take better care of its patients.”
This is worth understanding clearly, because it describes a real revenue model. When a software vendor mandates a payment processor or a claims switch, the vendor typically earns on that traffic. The pharmacy pays for it in rates it did not negotiate and cannot easily leave. Owners rarely see the arrangement itself — they see a processing rate that is slightly worse than what they could get on the open market, on volume they cannot move.
Datascan also reaffirmed a commitment to transparent pricing without forced add-ons, surprise fees or mandatory vendor arrangements.
Support, and the AI Question
Minassian drew a line on support staffing that most vendors are currently walking the other way across.
“We will not replace anyone in our support team with an AI agent ever,” he said. “Live, quick response support is one of the most important things we provide.”
That is a strong claim in a year when nearly every software category is routing tier-one support through automated agents. Whether it holds is a fair thing for owners to watch. The company says many of its employees have been with Datascan more than ten years, and that it intends to keep investing in experienced support personnel and programmers who understand pharmacy operations rather than consolidating support to lower cost.
What Datascan Says It Is Building
The company describes an integrated ecosystem covering its core pharmacy management platform, point of sale, a patient-facing mobile application, delivery management, workflow automation, central store management, long-term care and compounding, plus integrations with roughly 100 third-party pharmacy technology providers.
Minassian said investment will continue and accelerate, and specifically framed it as not being made with a sale in mind. That is the part of the announcement a buyer would find least convenient, which is arguably the point.
What This Means for Independent Pharmacies
Take the announcement for what it is: one vendor stating a position. It is not an industry trend, and it does not change anyone’s contract. What it does is make the question legitimate to ask out loud.
If you are evaluating a pharmacy software vendor — or renewing with the one you have — ownership structure now belongs on the same page as features and price. So does the processor question, which is the one most likely to be quietly costing you money right now.
Takeaways
Datascan’s announcement is a competitive position as much as a philosophy. The company is selling independence to independents, and that is a coherent pitch in a consolidating market. It is also, for once, a pitch that can be tested against behavior over time.
The broader signal is the more useful one. Pharmacy owners have spent a decade watching their choices narrow — in wholesalers, in PBM contracts, in payer networks. Software is the same story arriving later. Owners who treat vendor ownership as a diligence item rather than a footnote will be better positioned than owners who find out during a transition email.
Frequently Asked Questions
Is Datascan legally prevented from selling?
No. This is a public commitment from the company’s president and owner, not a binding restriction. It is a statement of intent that can be evaluated against the company’s actions over time.
Why does a software vendor mandating a payment processor matter?
Because the vendor generally earns revenue on that transaction flow. The pharmacy ends up paying rates it did not negotiate, on volume it cannot move to a competing processor without leaving the software platform entirely.
What should I ask my own software vendor?
Three questions: who owns you, are you for sale, and am I required to use your processor or claims switch. The answers, and the willingness to give them in writing, tell you most of what you need to know.
Does this change anything for pharmacies not on Datascan?
Not directly. But it establishes a benchmark other vendors can now be asked to match — on ownership, on processor freedom and on human support.
